We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.2B
AUM Growth
-$244M
(-2.1%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.7M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$34.3M |
| 3 |
Moderna
MRNA
|
+$29.3M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$18.3M |
| 5 |
Match Group
MTCH
|
+$9.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$35.7M |
| 2 |
Microsoft
MSFT
|
+$14.2M |
| 3 |
Apple
AAPL
|
+$13.2M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$9.28M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$6.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.19% |
| 2 | Financials | 13.17% |
| 3 | Healthcare | 12.67% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EAR
2526
DELISTED
Eargo, Inc. Common Stock
EAR
| $53.7K | ﹤0.01% |
399
| – | – |
|
2527
Century Casinos
CNTY
$34.3M
| $53.4K | ﹤0.01% |
3,968
-6,527
| -62% | -$82.9K |
|
2528
CuriosityStream
CURI
$166M
| $51.6K | ﹤0.01% |
4,891
-7,418
| -60% | -$87.3K |
|
|
AMPE
2529
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $51.4K | ﹤0.01% |
103
-161
| -61% | -$74.6K |
|
2530
Primis Financial Corp
FRST
$411M
| $51.1K | ﹤0.01% |
3,536
-5,886
| -62% | -$88K |
|
2531
CytomX Therapeutics
CTMX
$760M
| $50.3K | ﹤0.01% |
9,880
-16,228
| -62% | -$86.9K |
|
2532
Babcock & Wilcox
BW
$1.46B
| $50.1K | ﹤0.01% |
7,822
-13,352
| -63% | -$93.2K |
|
|
CAMP
2533
DELISTED
CalAmp Corp.
CAMP
| $49.7K | ﹤0.01% |
217
-340
| -61% | -$89.9K |
|
|
FPI
2534
Farmland Partners
FPI
$425M
| $49.1K | ﹤0.01% |
4,096
-6,481
| -61% | -$79.9K |
|
2535
Theravance Biopharma
TBPH
$878M
| $48.5K | ﹤0.01% |
6,554
-11,970
| -65% | -$134K |
|
2536
Tilly's
TLYS
$121M
| $44.5K | ﹤0.01% |
3,178
-5,590
| -64% | -$84.9K |
|
2537
Lineage Cell Therapeutics
LCTX
$278M
| $41.9K | ﹤0.01% |
16,627
-33,932
| -67% | -$87.1K |
|
|
VIRX
2538
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $40.7K | ﹤0.01% |
5,069
-9,638
| -66% | -$95K |
|
|
RRD
2539
DELISTED
RR Donnelley & Sons Co.
RRD
| $40.6K | ﹤0.01% |
7,901
-19,052
| -71% | -$102K |
|
2540
Astronics
ATRO
$4.34B
| $40.1K | ﹤0.01% |
3,424
-7,603
| -69% | -$96.5K |
|
2541
Select Water Solutions
WTTR
$2.73B
| $40K | ﹤0.01% |
7,710
-14,957
| -66% | -$82.3K |
|
2542
The Honest Company
HNST
$544M
| $39.8K | ﹤0.01% |
3,839
-7,739
| -67% | -$94.5K |
|
2543
Kodak
KODK
$992M
| $38.3K | ﹤0.01% |
5,624
-11,533
| -67% | -$84.2K |
|
|
LUNA
2544
DELISTED
Luna Innovations Incorporated
LUNA
| $37.1K | ﹤0.01% |
3,903
-8,003
| -67% | -$86.4K |
|
|
NAGE
2545
Niagen Bioscience
NAGE
$242M
| $37K | ﹤0.01% |
5,907
-12,993
| -69% | -$107K |
|
2546
Commercial Vehicle Group
CVGI
$128M
| $36.9K | ﹤0.01% |
3,901
-8,572
| -69% | -$81.1K |
|
|
HT
2547
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $36.6K | ﹤0.01% |
3,928
-8,699
| -69% | -$82.6K |
|
2548
Teekay Tankers
TNK
$2.81B
| $35.6K | ﹤0.01% |
2,450
-6,809
| -74% | -$83.4K |
|
|
ATNX
2549
DELISTED
Athenex, Inc. Common Stock
ATNX
| $35.3K | ﹤0.01% |
587
-1,153
| -66% | -$83.9K |
|
|
BFX
2550
DELISTED
BowFlex Inc.
BFX
| $32.8K | ﹤0.01% |
3,518
-7,732
| -69% | -$99.3K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
- MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
- MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
- MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
- MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
- MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.
Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.